.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Union Ayush Ministry recently introduced comprehensive Yoga protocols for NCDs. This initiative aims to transform India's healthcare landscape from treatment to prevention. Minister Prataprao Jadhav launched the program during Yoga Mahotsav 2026. Consequently, healthcare providers now have structured tools to address the rising burden of lifestyle diseases. These modules offer a scalable solution for a diverse population like India.
The WHOCCIND 118 team developed these modules using evidence-based routines for chronic conditions. For instance, the diabetes module improves metabolic balance and glycaemic control. Meanwhile, the hypertension routine regulates the nervous system and blood pressure. Doctors can recommend these daily sessions, which range from 30 to 60 minutes. Furthermore, the protocols combine asanas, pranayama, and meditation. This holistic approach ensures that patients receive sustainable health benefits over time.
The initiative covers more than just adult chronic illnesses. It includes playful modules for young children and mobility routines for the elderly. Additionally, specialized guidelines support pregnant women and adolescents. Therefore, the protocols serve as a lifelong health companion for diverse age groups. Emotional well-being also remains a primary focus within the guidelines. Dedicated practices aim to reduce stress and anxiety among patients. This shift significantly reduces long-term pressure on India's medical infrastructure.
Q1: What conditions do the new yoga protocols specifically target?
The protocols target major non-communicable diseases including diabetes, hypertension, cardiovascular ailments, bronchial asthma, and mental health disorders.
Q2: Who developed these evidence-based yoga modules?
The World Health Organisation Collaborating Centre for Traditional Medicine (Yoga) at the Morarji Desai National Institute of Yoga developed these modules under the Ministry of Ayush.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Union Ayush Ministry launches evidence-based Yoga protocols to tackle NCDs like diabetes and hypertension, focusing on preventive healthcare across Indi...
5 months ago
A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
